| Financial Year |
March 31 2023 |
| Monetary Funds |
37,190,934,370.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
-- |
| Accounts Receivable |
920,697,239.77 |
| Advances to Suppliers |
1,841,043,765.05 |
| Other Receivables |
32,214,705,593.00 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
2,476,257,376.61 |
| Dividend Receivable |
300,944,039.77 |
| Inventories |
199,518,034,203.74 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
11,357,498,008.56 |
| Other Current Assets |
14,357,329,438.23 |
| Total Current Assets |
297,400,242,618.51 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
160,000,000.00 |
| Long-term Equity Investment |
20,490,514,687.36 |
| Investment Properties |
14,499,879,902.55 |
| Fixed Assetes |
23,420,759,695.45 |
| Under-construction Projects |
5,921,156,917.22 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
11,897,572,429.09 |
| R&D expenses |
-- |
| Goodwill |
63,484,720.88 |
| Long-Term Deferred and Prepaid Expenses |
1,525,725,345.66 |
| Deferred Income Tax Assets |
12,777,716,198.95 |
| Other Non-Current Assets |
2,720,227,504.43 |
| Sub-Total of Non-Current Assets |
97,402,180,393.79 |
| Total Assets |
394,802,423,012.30 |
| Short-Term Loans |
4,427,118,822.65 |
| Trading Financial liabilities |
-- |
| Notes Payable |
22,787,498.64 |
| Accounts Payable |
31,147,987,063.62 |
| Accounts Received In Advance |
292,676,451.99 |
| Employee Compensation Payable |
2,351,801,610.96 |
| Taxes Payable |
3,180,723,741.33 |
| Interest Payable |
1,349,544,421.96 |
| Dividend Payable |
107,109,411.34 |
| Other payables |
55,852,232,462.20 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
15,957,987,731.66 |
| Other Current Liabilities |
4,815,449,970.14 |
| Sub-Total of Current Liabilities |
175,959,159,490.24 |
| Long-term Loans |
111,433,072,943.72 |
| Bonds Payable |
2,754,177,579.44 |
| Long-Term Accounts Payable |
327,262,842.26 |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
266,021,562.49 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
118,192,344,765.67 |
| Total Liabilities |
294,151,504,255.91 |
| Paid-In Capital(Or Share Stock) |
8,201,793,915.00 |
| Capital Surplus |
5,406,125,825.17 |
| Surplus Reserve |
4,921,485,082.64 |
| LESS:Treasury Stock |
1,041,515,155.83 |
| Undistributed Profits |
49,893,358,152.89 |
| Minority Stockholder's Interest |
32,005,809,158.84 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
68,645,109,597.55 |
| Owner's Equity（Stockholder's Equity） |
100,650,918,756.39 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
394,802,423,012.30 |
